GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin's lymphoma patients

Archives of Gynecology and Obstetrics

Volumn 282, Issue 1, 2010, Pages 83-88

  Nitzschke, Markus ^a   Raddatz, Juliane ^b   Bohlmann, Michael K ^c   Stute, Petra ^a   Strowitzki, Thomas ^b   Von Wolff, Michael ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Cancer; Chemotherapy; Fertility preservation; GnRH analogs; Hodgkin's lymphoma; Ovarian reserve

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FOLLITROPIN; GOSERELIN; INHIBIN B; LEUPRORELIN; MUELLERIAN INHIBITING FACTOR; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE SULFATE; ANTINEOPLASTIC AGENT; GONADORELIN; INHIBIN;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HODGKIN DISEASE; HUMAN; MULTIPLE CYCLE TREATMENT; OVARY DISEASE; PROTECTION; TREATMENT OUTCOME; AGONISTS; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; ECHOGRAPHY; OVARY; PATHOLOGY; PRIMARY OVARIAN INSUFFICIENCY; ULTRASTRUCTURE; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-MULLERIAN HORMONE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HODGKIN DISEASE; HUMANS; INHIBINS; OVARIAN DISEASES; OVARIAN FAILURE, PREMATURE; OVARY; ULTRASONOGRAPHY; YOUNG ADULT; PRIMARY OVARIAN INSUFFICIENCY;

EID: 77953650099     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-009-1308-5     Document Type: Article

References (22)

1. D Meirow D Nugent 2001 The effects of radiotherapy and chemotherapy on female reproduction Hum Reprod Update 7 535 543 10.1093/humupd/7.6.535 1:STN:280:DC%2BD3MnotFKisQ%3D%3D 11727861 (Pubitemid 33069611)
2. M Sonmezer K Oktay 2004 Fertility preservation in female patients Hum Reprod Update 10 251 266 10.1093/humupd/dmh021 15140872 (Pubitemid 38744870)
3. Z Blumenfeld I Avivi M Ritter JM Rowe 1999 Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women J Soc Gynecol Investig 6 229 239 10.1016/S1071-5576(99)00028-3 1:STN:280:DC%2BD3c%2Fit1Cisw%3D%3D 10554760 (Pubitemid 29494928)
4. LM Glode J Robinson SF Gould 1981 Protection from cyclophosphamide- induced testicular damage with an analogue of gonadotropin-releasing hormone Lancet 1 1132 1134 10.1016/S0140-6736(81)92301-1 1:CAS:528:DyaL3MXltVymtro%3D 6112490
5. K Oktay M Sönmezer O Oktem K Fox G Emons H Bang 2007 Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury Oncologist 12 1055 1066 10.1634/theoncologist.12-9-1055 1:CAS:528:DC%2BD2sXht1Krs73I 17914075 (Pubitemid 350007017)
6. Z Blumenfeld M von Wolff 2008 GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy Hum Reprod Update 14 543 552 10.1093/humupd/dmn022 1:CAS:528:DC%2BD1cXht1Ois7%2FP 18824495
7. R Beck-Fruchter A Weiss E Shalev 2008 GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data Hum Reprod Update 14 541 542 10.1093/humupd/dmn041
8. ME Clowse MA Behera CK Anders S Copland CJ Coffman PC Leppert LA Bastian 2009 Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis J Womens Health 18 311 319 10.1089/jwh.2008.0857
9. A Badawy A Elnashar M El-Ashry M Shahat 2009 Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study Fertil Steril 91 694 697 10.1016/j.fertnstert.2007. 12.044 1:CAS:528:DC%2BD1MXnslWms7k%3D 18675959
10. LE Bath WH Wallace MP Shaw C Fitzpatrick RA Anderson 2003 Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound Hum Reprod 18 2368 2374 10.1093/humrep/deg473 1:CAS:528:DC%2BD3sXovVektLs%3D 14585889 (Pubitemid 37427819)
11. EC Larsen J Müller C Rechnitzer K Schmiegelow AN Andersen 2003 Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH < 10 IU/l Hum Reprod 18 417 422 10.1093/humrep/deg073 1:CAS:528:DC%2BD3sXit1yrt7s%3D 12571182 (Pubitemid 36236279)
12. RA Anderson AP Themmen A Al-Qahtani NP Groome DA Cameron 2006 The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer Hum Reprod 21 2583 2592 10.1093/humrep/del201 1:CAS:528:DC%2BD28XhtVWlt73N 16820385 (Pubitemid 44542149)
13. C Avril 2006 Antral follicle count and oocyte quality J Gynecol Obstet Biol Reprod 35 2S42 2S43 1:STN:280:DC%2BD28nitlGqug%3D%3D
14. EJ Pavlik PD DePriest HH Gallion FR Ueland MB Reedy RJ Kryscio, et al. 2000 Ovarian volume related to age Gynecol Oncol 77 410 412 10.1006/gyno.2000. 5783 1:STN:280:DC%2BD3c3ptlSrug%3D%3D 10831351 (Pubitemid 30368559)
15. K Ataya E Pydyn A Ramahi-Ataya CG Orton 1995 Is radiation-induced ovarian failure in rhesus monkeys preventable by luteinizing hormone-releasing hormone agonists?: preliminary observations J Clin Endocrinol Metab 80 790 795 10.1210/jc.80.3.790 1:CAS:528:DyaK2MXktlOntrc%3D 7883832
16. K Ataya LV Rao E Lawrence R Kimmel 1995 Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys Biol Reprod 52 365 372 10.1095/biolreprod52.2.365 1:CAS:528:DyaK2MXjt12ksr0%3D 7711205
17. JH Waxman R Ahmed D Smith PF Wrigley W Gregory S Shalet, et al. 1987 Failure to preserve fertility in patients with Hodgkin's disease Cancer Chemother Pharmacol 19 159 162 10.1007/BF00254570 1:STN:280:DyaL2s7ovVSlug%3D%3D 3105906
18. A Sverrisdottir M Nystedt H Johansson T Fornander 2009 Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial Breast Cancer Res Treat 117 561 567 10.1007/s10549-009-0313-5 1:CAS:528:DC%2BD1MXhtFegtbbK 19153828
19. C Teinturier O Hartmann D Valteau-Couanet E Benhamou PF Bougneres 1998 Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure Bone Marrow Transplant 22 989 994 10.1038/sj.bmt.1701483 1:STN:280:DyaK1M%2FmsV2nug%3D%3D 9849696
20. AP Grigg R McLachlan J Zaja J Szer 2000 Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg) Bone Marrow Transplant 26 1089 1095 10.1038/sj.bmt.1702695 1:STN:280: DC%2BD3Mzgtlyitg%3D%3D 11108308
21. S Viviani A Santoro G Ragni V Bonfante O Bestetti G Bonadonna 1985 Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD Eur J Cancer Clin Oncol 21 601 605 10.1016/0277-5379(85)90088-4 1:STN:280:DyaL2M3jtVynsA%3D%3D 2408897 (Pubitemid 15116991)
22. L Giuseppe G Attilio DN Edoardo G Loredana L Cristina L Vincenzo 2007 Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD) Hematology 12 141 147 10.1080/10245330600954072 17454195 (Pubitemid 46605523)